Mary E. Ritchey

1.1k total citations
32 papers, 564 citations indexed

About

Mary E. Ritchey is a scholar working on Economics and Econometrics, Statistics and Probability and Neurology. According to data from OpenAlex, Mary E. Ritchey has authored 32 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Economics and Econometrics, 9 papers in Statistics and Probability and 6 papers in Neurology. Recurrent topics in Mary E. Ritchey's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Statistical Methods in Clinical Trials (9 papers) and Peripheral Neuropathies and Disorders (3 papers). Mary E. Ritchey is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), Statistical Methods in Clinical Trials (9 papers) and Peripheral Neuropathies and Disorders (3 papers). Mary E. Ritchey collaborates with scholars based in United States, Japan and Austria. Mary E. Ritchey's co-authors include Cynthia J. Girman, Vincent Lo Re, Jingwei Wu, Michael D. Murray, Wanzhu Tu, Heather E. Danysh, Michelle D. Hackshaw, Corina Taitt, Charles A. Powell and Wei Zhou and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Neurology.

In The Last Decade

Mary E. Ritchey

29 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary E. Ritchey United States 13 97 91 89 78 73 32 564
Diogo Mendes Portugal 16 70 0.7× 129 1.4× 68 0.8× 51 0.7× 39 0.5× 40 796
Aarthi Iyer United States 10 81 0.8× 85 0.9× 30 0.3× 29 0.4× 58 0.8× 15 411
Giuseppe Roberto Italy 15 84 0.9× 117 1.3× 108 1.2× 34 0.4× 64 0.9× 50 726
Elvira D’Andrea United States 22 212 2.2× 155 1.7× 79 0.9× 32 0.4× 68 0.9× 62 1.1k
Mugdha Gokhale United States 14 75 0.8× 122 1.3× 137 1.5× 16 0.2× 52 0.7× 31 603
Ylenia Ingrasciotta Italy 17 143 1.5× 78 0.9× 21 0.2× 83 1.1× 70 1.0× 44 789
Joshua Ray Switzerland 15 294 3.0× 90 1.0× 61 0.7× 22 0.3× 45 0.6× 45 875
Brigitte Bloechl‐Daum Austria 8 294 3.0× 83 0.9× 55 0.6× 26 0.3× 27 0.4× 8 939
Romin Pajouheshnia Netherlands 12 100 1.0× 34 0.4× 52 0.6× 18 0.2× 148 2.0× 21 573
Greg Carney Canada 12 53 0.5× 75 0.8× 19 0.2× 44 0.6× 44 0.6× 37 620

Countries citing papers authored by Mary E. Ritchey

Since Specialization
Citations

This map shows the geographic impact of Mary E. Ritchey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. Ritchey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. Ritchey more than expected).

Fields of papers citing papers by Mary E. Ritchey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary E. Ritchey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. Ritchey. The network helps show where Mary E. Ritchey may publish in the future.

Co-authorship network of co-authors of Mary E. Ritchey

This figure shows the co-authorship network connecting the top 25 collaborators of Mary E. Ritchey. A scholar is included among the top collaborators of Mary E. Ritchey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary E. Ritchey. Mary E. Ritchey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tennant, Bethany, et al.. (2024). Communicating medical device recalls: A rapid review of the literature. Patient Education and Counseling. 123. 108244–108244. 1 indexed citations
2.
Fassett, Michael J., Susan D. Reed, Kenneth J. Rothman, et al.. (2023). Risks of Uterine Perforation and Expulsion Associated With Intrauterine Devices. Obstetrics and Gynecology. 142(3). 641–651. 9 indexed citations
3.
Rosen, Emma M., Mary E. Ritchey, & Cynthia J. Girman. (2023). Can Weight of Evidence, Quantitative Bias, and Bounding Methods Evaluate Robustness of Real-world Evidence for Regulator and Health Technology Assessment Decisions on Medical Interventions?. Clinical Therapeutics. 45(12). 1266–1276. 1 indexed citations
4.
Wang, Jingjun, Mary E. Ritchey, K R Reynolds, et al.. (2023). Assessment of Codispensing Patterns of Mirabegron and Prespecified CYP2D6 Substrates in Patients with Overactive Bladder. Drugs - Real World Outcomes. 10(3). 439–446. 1 indexed citations
5.
6.
Layton, J. Bradley, et al.. (2023). Intravenous Immunoglobulin Initiation in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims-based Cohort Study. Neurology and Therapy. 12(4). 1171–1186. 1 indexed citations
7.
Girman, Cynthia J., Mary E. Ritchey, & Vincent Lo Re. (2022). Real‐world data: Assessing electronic health records and medical claims data to support regulatory decision‐making for drug and biological products. Pharmacoepidemiology and Drug Safety. 31(7). 717–720. 95 indexed citations
8.
Chang, Ellen T., et al.. (2022). Use of Contrave, Naltrexone with Bupropion, Bupropion, or Naltrexone and Major Adverse Cardiovascular Events: A Systematic Literature Review. Diabetes Metabolic Syndrome and Obesity. Volume 15. 3049–3067. 6 indexed citations
9.
Girman, Cynthia J., Mary E. Ritchey, Ann McNeill, Karolina Andersson Sundell, & Robert J. Meyer. (2021). Demonstrating that Real World Evidence Is Fit-For-Purpose to Support Labeling: Parallels to Patient Reported Outcomes in the Pursuit of Labeling Claims. Therapeutic Innovation & Regulatory Science. 55(3). 561–567. 3 indexed citations
10.
Hackshaw, Michelle D., Heather E. Danysh, Nora Tu, et al.. (2021). Prognostic factors of brain metastasis and survival among HER2-positive metastatic breast cancer patients: a systematic literature review. BMC Cancer. 21(1). 967–967. 28 indexed citations
11.
Layton, J. Bradley, Joan Forns, Mary Ellen Turner, et al.. (2021). Falls and Fractures in Patients with Parkinson’s Disease-Related Psychosis Treated with Pimavanserin vs Atypical Antipsychotics: A Cohort Study. Drugs - Real World Outcomes. 9(1). 9–22. 18 indexed citations
12.
13.
Forns, Joan, J. Bradley Layton, Mary Ellen Turner, et al.. (2021). Increased risk of falls and fractures in patients with psychosis and Parkinson disease. PLoS ONE. 16(1). e0246121–e0246121. 12 indexed citations
14.
Hackshaw, Michelle D., Heather E. Danysh, Jasmeet Singh, et al.. (2020). Incidence of pneumonitis/interstitial lung disease induced by HER2-targeting therapy for HER2-positive metastatic breast cancer. Breast Cancer Research and Treatment. 183(1). 23–39. 66 indexed citations
15.
Hackshaw, Michelle D., et al.. (2020). Review of survival, safety, and clinical outcomes in HER2+ metastatic gastric cancer following the administration of trastuzumabPost-Trastuzumab Gastric Cancer. Cancer Treatment and Research Communications. 24. 100189–100189. 2 indexed citations
16.
Girman, Cynthia J., Mary E. Ritchey, Wei Zhou, & Nancy A Dreyer. (2018). Considerations in characterizing real‐world data relevance and quality for regulatory purposes: A commentary. Pharmacoepidemiology and Drug Safety. 28(4). 439–442. 29 indexed citations
17.
Brodovicz, Kimberly G., Yong Chen, Zhiwen Liu, et al.. (2015). Characterization of Sitagliptin Use in Patients with Type 2 Diabetes and Chronic Kidney Disease by Cross-Sectional Analysis of a Medical Insurance Claims Database. Diabetes Therapy. 6(4). 627–634. 5 indexed citations
18.
Jalbert, Jessica J., et al.. (2014). Methodological Considerations in Observational Comparative Effectiveness Research for Implantable Medical Devices: An Epidemiologic Perspective. American Journal of Epidemiology. 180(9). 949–958. 6 indexed citations
19.
Loring, Zak, Daniel Caños, Kimberly A. Selzman, et al.. (2013). Left Bundle Branch Block Predicts Better Survival in Women Than Men Receiving Cardiac Resynchronization Therapy. JACC Heart Failure. 1(3). 237–244. 39 indexed citations
20.
Goldman, Michel, Susan E. Clare, Robert E. Emerson, et al.. (2009). Idiopathic granulomatous mastitis in hispanic women - Indiana, 2006-2008.. MMWR Morbidity and Mortality Weekly Report. 58(47). 1317–1321. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Diogo Mendes Breakdown of academic impact, for papers by Aarthi Iyer Breakdown of academic impact, for papers by Giuseppe Roberto Breakdown of academic impact, for papers by Elvira D’Andrea Breakdown of academic impact, for papers by Mugdha Gokhale Breakdown of academic impact, for papers by Ylenia Ingrasciotta Breakdown of academic impact, for papers by Joshua Ray Breakdown of academic impact, for papers by Brigitte Bloechl‐Daum Breakdown of academic impact, for papers by Romin Pajouheshnia Breakdown of academic impact, for papers by Greg Carney
Rankless by CCL
2026